LabCorp (NYSE: LH), the global lab testing firm based in Burlington, and its Chief Executive Officer David King are the host for “Venture Day” at the CED’s annual life science conference.
LabCorp executives will discuss the firm’s strategy, partnering opportunities and acquisition targets for the coming year.
Venture Day is a recent addition to the conference in which startups and emerging companies are provided opportunities to discuss possible deals and alliances with larger firms.
The CED conference is set for Feb. 27-28 in Raleigh.
The North Carolina Biotechnology Center and NCBIO partner with CED to put on the event.
Presenting biopharma companies at the conference include:
- Aerial Biopharma
- Clinipace Worldwide
- Clinverse
- GeneCentric
- Metabolon
- Oncotide
- Liquidia Technologies
Presenting medtech companies include:
- Advanced Animal Diagnostics
- Clearside Biomedical
- e-Nicotine Technology
- Inclinix
- MX Biodevices
- Physcient
- TearScience
- TransEnterix
